GeneGene: CD274
PD-L1 (CD274)
PD-L1 is an immune checkpoint ligand tumors use to evade T-cell attack. Anti-PD-L1 antibodies block that brake and are a backbone of modern cancer immunotherapy, frequently combined with other agents to broaden response.
1
Drugs
1
Trials tracked
0
Resolved
1
Indications
Drugs hitting this target
Trials targeting PD-L1
1 benchmarkIndications
About PD-L1
What is PD-L1?
PD-L1 is an immune checkpoint ligand tumors use to evade T-cell attack. Anti-PD-L1 antibodies block that brake and are a backbone of modern cancer immunotherapy, frequently combined with other agents to broaden response.
Which drugs target PD-L1?
Therapies acting on PD-L1 tracked here include Durvalumab.